home / stock / qure / qure news


QURE News and Press, uniQure N.V. From 02/27/26

Stock Information

Company Name: uniQure N.V.
Stock Symbol: QURE
Market: NASDAQ
Website: uniqure.com

Menu

QURE QURE Quote QURE Short QURE News QURE Articles QURE Message Board
Get QURE Alerts

News, Short Squeeze, Breakout and More Instantly...

QURE - uniQure Q4 2025 Earnings Preview

2026-02-27 10:47:32 ET More on uniQure uniQure: Now What? uniQure: Why Waiting For Clarity Beats Chasing The Next Step Jump uniQure falls after FDA commissioner’s comments on rare disease therapy uniQure gains as FDA sets up meeting on gene therapy ...

QURE - US Companies Moving the Markets, Morning edition
Fri, Feb 27, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 8.2% to $1.72 on volume of 989,059,874 shares NVIDIA Corporation (NVDA) fell 5.5% to $184.89 on volume of 360,807,907 shares Avalon GloboCare Corp. (ALBT) rose 114.5% to $1.09 on v...

QURE - US Companies Moving the Markets, Evening edition
Thu, Feb 26, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 10.7% to $1.76 on volume of 915,226,798 shares NVIDIA Corporation (NVDA) fell 5.7% to $184.355 on volume of 298,520,855 shares Avalon GloboCare Corp. (ALBT) rose 81.8% to $0.9239 o...

QURE - uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses

uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses PR Newswire SAN DIEGO , Feb. 26, 2026 /PRNewswire/ --  Robbins LLP reminds stockholders that a class action was filed on behal...

QURE - uniQure falls after FDA commissioner's comments on rare disease therapy

2026-02-26 10:20:14 ET More on uniQure uniQure: Now What? uniQure: Why Waiting For Clarity Beats Chasing The Next Step Jump uniQure gains as FDA sets up meeting on gene therapy uniQure stock falls after FDA's notes on pre application of AMT-130 Seekin...

QURE - QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role

If you have suffered a loss on your uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com , or fill out the contact form below to discuss your rights or interests ...

QURE - uniQure to Announce 2025 Financial Results

LEXINGTON, Mass. and AMSTERDAM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report fourth quarter and full year of 2025 financial results before market open on Monday...

QURE - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE PR Newswire NEW YORK , Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of uniQure N.V. (NASDAQ: QURE). Sha...

QURE - uniQure N.V. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights - QURE

uniQure N.V. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights - QURE uniQure N.V. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights - QURE PR Newswire NEW YO...

QURE - Diamond Hill International Strategy Q4 2025 Portfolio Review

2026-02-17 02:14:00 ET ... Read the full article on Seeking Alpha For further details see: Diamond Hill International Strategy Q4 2025 Portfolio Review

Previous 10 Next 10